The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 01, 2022

Filed:

Jun. 13, 2018
Applicants:

Thomas Jefferson University, Philadelphia, PA (US);

Icahn School of Medicine AT Mount Sinai, New York, NY (US);

Inventors:

Matthias Schnell, Harleysville, PA (US);

Christine Rettew Fisher, Philadelphia, PA (US);

Christoph Wirblich, Philadelphia, PA (US);

Gene Tan, La Jolla, CA (US);

Assignees:

Thomas Jefferson University, Philadelphia, PA (US);

ICAHN School of Medicine at Mount Sinai, New York, NY (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/12 (2006.01); C12N 15/86 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 39/12 (2013.01); C12N 15/86 (2013.01); A61K 2039/5252 (2013.01); A61K 2039/53 (2013.01); C12N 2760/20134 (2013.01);
Abstract

The present disclosure is directed towards chimeric glycoproteins wherein the clip region, a core region, a flap region, and a transmembrane and cytoplasmic domain are defined by starting from the amino terminus of the protein, these domains are comprised of the following amino acid residue ranges: clip, 1 through 40 to 60; core, 40 to 60 through 249 to 281; flap, 249 to 281 through 419 to 459; the transmembrane domain is comprised of amino acids 460 through 480, and the remaining amino acids 481 through 525 comprise the cytoplasmic domain; and wherein the clip, core, flap, transmembrane, and cytoplasmic domain comprise a chimeric combination of at least two lyssavirus, wherein the chimeric glycoprotein is advantageously inserted into a rabies-based vaccine vector.


Find Patent Forward Citations

Loading…